Of politics, prostate cancer, screening, and editorial opinions

We don’t often refer to articles in what are primarily political publications like The Hill, but an OpEd in that journal this week did catch our attention, and not in a particularly good way either. … READ MORE …

PSA testing in the “real world” … from 2010 to 2015

A newly published article in the journal Cancer suggests that, in fact, the USPSTF guidance on use of the PSA test for risk of prostate cancer has had little impact in the “real world” between 2010 and 2015 (at least at one large tertiary care institution in Texas). … READ MORE …

The impact of the USPSTF recommendation against screening: another take

A research letter from the epidemiologists and statisticians at the American Cancer Society has just been published in JAMA Oncology. The full text of the research letter is available on line. … READ MORE …

The politics of PSA testing

We continue to see a steady stream of articles in the cancer literature that appears to be designed to influence the thinking of the U.S. Preventive Services Task Force (USPSTF) as they reconsider the value of PSA testing in assessment of risk for prostate cancer. … READ MORE …

MRI scanning as a screening test for prostate cancer: data from a pilot study

A newly published study from the Sunnybrook group at the University of Toronto has investigated the possibility of MRI scanning as a method to screen men for risk of clinically significant prostate cancer. … READ MORE …

The systemic problems of the PCLO trial of PSA screening

A Letter to the Editor published in this week’s issue of the New England Journal of Medicine has, yet again, pointed out that the US-based PCLO trial was badly flawed and was never, in fact, a trial of screening against no screening. … READ MORE …

PCPC3 notes revisions to USPSTF research plan on PSA screening

PCPC3 — the patient-centered prostate cancer collaborative coalition — has just issued a statement about the revised research plan issued by the U.S. Preventive Services Task Force (USPSTF) in reassessing the value of PSA screening for risk of prostate cancer. … READ MORE …